Unique ID issued by UMIN | UMIN000058436 |
---|---|
Receipt number | R000066770 |
Scientific Title | Study to confirm absorption of carotenoids in trial foods |
Date of disclosure of the study information | 2025/07/11 |
Last modified on | 2025/07/11 11:28:39 |
Study to confirm absorption of carotenoids in trial foods
Study to confirm absorption of carotenoids in trial foods
Study to confirm absorption of carotenoids in trial foods
Study to confirm absorption of carotenoids in trial foods
Japan |
Healthy volunteers
Not applicable | Adult |
Others
NO
To compare the absorption effectiveness of existing and new formulations in humans.
Pharmacokinetics
AUC of carotenoid (lutein/zeaxanthin/astaxanthin) concentration in blood
Blood carotenoid concentrations (lutein/ zeaxanthin/ astaxanthin) at each time point and Cmax
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Active
2
Prevention
Food |
The trial food will be consumed once, followed by a washout period, then the control food will be consumed once.
After consuming the control food once, a washout period will follow, and the test food will be consumed once.
20 | years-old | <= |
60 | years-old | > |
Male and Female
1) Japanese males and females aged 20 to under 60 at the time of informed consent.
2) Participants who with a BMI >=18.5 kg/m2 and <25kg/m2.
3) Participants who received a full explanation of the study and signed the informed consent form before study initiation.
1) Participants with a history of serious illness or gastrointestinal surgery.
2) Participants with diseases affecting gastric emptying or digestion/absorption, or who regularly experience symptoms such as indigestion, constipation, or diarrhea.
3) Participants with abnormal kidney or liver function, blood pressure, or glucose/lipid metabolism.
4) Participants who regularly use medications (including Kampo), or quasi-drugs or supplements.
5) Participants who regularly consume health foods (e.g., FOSHU, foods with functional claims) that may affect the study and cannot discontinue them during the study period.
6) Participants who consume excessive amounts of alcohol.
7) Participants who Currently smoke or have smoked within the past year.
8) Participants planning to travel abroad during the study period.
9) Participant with irregular work hours or engaged in shift work.
10) Participants who may be unable to maintain their lifestyle due to dietary restrictions.
11) Participants with food allergies or those who may react to the trial or provided food.
12) Participants who are pregnant, breastfeeding, or planning to become pregnant during the study period.
13) Participants who joined another clinical trial within one month before consent or plan to join one during the study.
14) Participants deemed ineligible by the principal investigator.
20
1st name | Erika |
Middle name | |
Last name | Ono |
FANCL CORPORATION
Clinical Research Center ,Functional Food Research Institute
244-0806
12-13, Kamishinano, Totsuka-ku, Yokohama-shi, Kanagawa, 244-0806, Japan
045-820-3659
tsubokawa_masaya@fancl.co.jp
1st name | Shuka |
Middle name | |
Last name | Futagami |
APO PLUS STATION CO., LTD.
Clinical Operations Dept., CRO Business div.
103-0027
2-14-1, Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan
03-6777-7789
food-contact@apoplus.co.jp
APO PLUS STATION CO., LTD.
FANCL CORPORATION
Profit organization
Ethics Review Committee of Watanabe Hospital
1-5-16, Haneda, Otaku, Tokyo, 144-0043, Japan
03-3741-0223
food-contact@apoplus.co.jp
NO
医療法人社団 渡辺病院(東京都)
2025 | Year | 07 | Month | 11 | Day |
Unpublished
Preinitiation
2025 | Year | 07 | Month | 11 | Day |
2025 | Year | 07 | Month | 11 | Day |
2025 | Year | 07 | Month | 12 | Day |
2025 | Year | 12 | Month | 31 | Day |
2025 | Year | 07 | Month | 11 | Day |
2025 | Year | 07 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066770